跳至主要内容
临床试验/EUCTR2008-001881-10-IT
EUCTR2008-001881-10-IT进行中(未招募)不适用

Raltegravir/Atazanavir pharmacokinetics and evaluation of lipids - RAPHAE

AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)0 个研究点开始时间: 2008年6月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a. Inclusion i. Age > 18 years ii. Documented chronic HIV infection iii. Signed informed consent iv. Effective ongoing treatment (HIV-RNA < 50 copies/ml for longer than 6 months and at least in 3 evaluations). v. Dislipidemic profile (Total cholesterol > 300 mg/dl or TG > 400 mg) vi. No documented resistance to protease inhibitors
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • b. Exclusion i. Childbearing or breastfeeding. Women of childbearing potential will be asked to adopt effective contraceptive methods or behaviours ii. Any ongoing grade 4 laboratory abnormality, but for lipid alterations

研究者

发起方
AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)

相似试验